Inhibrx (NASDAQ:INBX) & Halozyme Therapeutics (NASDAQ:HALO) Head-To-Head Review
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Inhibrx (NASDAQ:INBX – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership. Profitability This table compares Halozyme Therapeutics and Inhibrx’s net […]
More Stories
Amid ‘clear’ threat of nuclear war, Guterres tells Security Council multilateral off-ramp is essential
Strengthening international cooperation and delivering on a UN pact that calls for reforming global governance, among other measures, was the...
DR Congo: Children reportedly killed in summary executions by M23 fighters
The humanitarian emergency in eastern Democratic Republic of the Congo (DRC) has deteriorated sharply with serious human rights violations and...
Blue Trust Inc. Sells 4,381 Shares of D.R. Horton, Inc. (NYSE:DHI)
Blue Trust Inc. lessened its stake in D.R. Horton, Inc. (NYSE:DHI – Free Report) by 58.2% during the 4th quarter,...
Schwab US Broad Market ETF (NYSEARCA:SCHB) Shares Bought by Valeo Financial Advisors LLC
Valeo Financial Advisors LLC increased its position in Schwab US Broad Market ETF (NYSEARCA:SCHB – Free Report) by 200.0% during...
Roman Butler Fullerton & Co. Cuts Stock Position in Tesla, Inc. (NASDAQ:TSLA)
Roman Butler Fullerton & Co. reduced its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 10.5% in the fourth...
Blue Trust Inc. Has $545,000 Stock Holdings in Spotify Technology S.A. (NYSE:SPOT)
Blue Trust Inc. decreased its holdings in shares of Spotify Technology S.A. (NYSE:SPOT – Free Report) by 16.4% during the...